Turkey Healthcare Infrastructure Investment and Finance Summit 2011



24 Feb 2011
Text size +-


Dear Subscriber,

The healthcare system in Turkey has entered a long period of development under the 2003-2013 Health Transformation Program.

Turkey is one of the fastest growing pharmaceutical markets in Europe and ranks as the 16th largest pharmaceutical producer in the world and the 6th largest pharmaceutical market in Europe, following Germany, France, the UK, Italy and Spain.

On the other hand, recent trends and current needs in the country's healthcare infrastructure development are opening up finance, consulting, and PPP opportunities as well as new investment channels.

The Summit will highlight issues related to med-tech development, new medical technology, hospital project development, IT and e-health opportunities, not to mention the booming medical/wellness tourism.

Follow the link for the full agenda and join your peers at this landmark Summit by registering now. Please note that subscribers will benefit of a 15% discount by quoting “THS15MP” on their registration so don’t miss this opportunity!

The Summit will enable you to explore key issues, network and build personal relationships with business and political decision-makers and to assess business opportunities in the development of healthcare infrastructure sector in Turkey. We expect a sell-out event with businessmen from many countries and thus an event not to be missed.


We have limited sponsorship (along with a speaking slot) and exhibition opportunities. To receive information on how you can increase awareness of your brand or re-affirm your status as a key player or major investor, please contact one of us or visit our website (corporate opportunities section).

Vanessa (T: +32 2 626 9663 - @: vmeys@euroconvention.com)
Claudio (T: +44 207 381 9291 - @:
Martin (T: +421 257 272855 - @:

We look forward to discussing further your participation to this Summit and the pleasure of welcoming you and your colleagues on this occasion.

Sincerely yours,

Tanguy de Craecker, Managing Director

Claudio Cassuto, Director


Covid-19 Economic Impact Assessments

Stay updated on how some of the world’s most promising markets are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues.

Register now and also receive a complimentary 2-month licence to the OBG Research Terminal.

Register Here×

Product successfully added to shopping cart